[?2026h[?25l[1G‚†ô [K[?25h[?2026l[?2026h[?25l[1G‚†ô [K[?25h[?2026l[?2026h[?25l[1G‚†π [K[?25h[?2026l[?2026h[?25l[1G‚†∏ [K[?25h[?2026l[?2026h[?25l[1G‚†¥ [K[?25h[?2026l[?2026h[?25l[1G‚†¥ [K[?25h[?2026l[?2026h[?25l[1G‚†¶ [K[?25h[?2026l[?2026h[?25l[1G‚†á [K[?25h[?2026l[?2026h[?25l[1G‚†á [K[?25h[?2026l[?2026h[?25l[1G‚†ã [K[?25h[?2026l[?2026h[?25l[1G‚†ô [K[?25h[?2026l[?2026h[?25l[1G‚†ô [K[?25h[?2026l[?2026h[?25l[1G‚†π [K[?25h[?2026l[?2026h[?25l[1G‚†∏ [K[?25h[?2026l[?2026h[?25l[1G‚†¥ [K[?25h[?2026l[?2026h[?25l[1G‚†¥ [K[?25h[?2026l[?2026h[?25l[1G‚†ß [K[?25h[?2026l[?2026h[?25l[1G‚†ß [K[?25h[?2026l[?2026h[?25l[1G‚†á [K[?25h[?2026l[?2026h[?25l[1G‚†è [K[?25h[?2026l[?2026h[?25l[1G‚†ô [K[?25h[?2026l[?2026h[?25l[1G‚†π [K[?25h[?2026l[?2026h[?25l[1G‚†π [K[?25h[?2026l[?2026h[?25l[1G‚†∏ [K[?25h[?2026l[?2026h[?25l[1G‚†¥ [K[?25h[?2026l[?2026h[?25l[1G‚†¥ [K[?25h[?2026l[?25l[?2026h[?25l[1G[K[?25h[?2026l[2K[1G[?25hThinking...
We[?25l[?25h need[?25l[?25h a[?25l[?25h thorough[?25l[?25h ethical[?25l[?25h reasoning[?25l[?25h,[?25l[?25h step[?25l[?25h-by[?25l[?25h-step[?25l[?25h,[?25l[?25h exploring[?25l[?25h duties[?25l[?25h to[?25l[?25h patients[?25l[?25h,[?25l[?25h society[?25l[?25h,[?25l[?25h company[?25l[?25h,[?25l[?25h colleagues[?25l[?25h.[?25l[?25h Lik[?25l[?25hely[?25l[?25h reference[?25l[?25h professional[?25l[?25h codes[?25l[?25h ([?25l[?25hHIP[?25l[?25hAA[?25l[?25h,[?25l[?25h FDA[?25l[?25h,[?25l[?25h Good[?25l[?25h Clinical[?25l[?25h Practice[?25l[?25h,[?25l[?25h Belmont[?25l[?25h report[?25l[?25h).[?25l[?25h Con[?25l[?25hclude[?25l[?25h that[?25l[?25h must[?25l[?25h report[?25l[?25h fals[?25l[?25hification[?25l[?25h to[?25l[?25h appropriate[?25l[?25h authorities[?25l[?25h ([?25l[?25hcompany[?25l[?25h internal[?25l[?25h compliance[?25l[?25h,[?25l[?25h possibly[?25l[?25h FDA[?25l[?25h).[?25l[?25h Discuss[?25l[?25h potential[?25l[?25h whistle[?25l[?25hblower[?25l[?25h protection[?25l[?25h,[?25l[?25h ways[?25l[?25h to[?25l[?25h mitigate harm[?25l[?25h,[?25l[?25h discuss[?25l[?25h personal[?25l[?25h and[?25l[?25h professional[?25l[?25h consequences[?25l[?25h,[?25l[?25h and[?25l[?25h propose[?25l[?25h approach[?25l[?25h to[?25l[?25h handle[?25l[?25h situation[?25l[?25h ([?25l[?25hdocument[?25l[?25h evidence[?25l[?25h,[?25l[?25h discuss[?25l[?25h with[?25l[?25h colleague[?25l[?25h,[?25l[?25h escalate[?25l[?25h).[?25l[?25h Provide[?25l[?25h robust[?25l[?25h reasoning[?25l[?25h.[?25l[?25h Should[?25l[?25h be[?25l[?25h thoughtful[?25l[?25h,[?25l[?25h not[?25l[?25h just[?25l[?25h "[?25l[?25hreport[?25l[?25h".[?25l[?25h Should[?25l[?25h be[?25l[?25h thorough[?25l[?25h.[?25l[?25h Let's[?25l[?25h do[?25l[?25h it[?25l[?25h.[?25l[?25h
...done thinking.

**[?25l[?25hShort[?25l[?25h answer[?25l[?25h:**[?25l[?25h‚ÄØ[?25l[?25hYou[?25l[?25h must[?25l[?25h report[?25l[?25h the[?25l[?25h fals[?25l[?25hified data[?25l[?25h ‚Äì[?25l[?25h first[?25l[?25h internally[?25l[?25h ([?25l[?25hthrough[?25l[?25h the[?25l[?25h company[?25l[?25h‚Äôs[?25l[?25h compliance[?25l[?25h /[?25l[?25h quality[?25l[?25h‚Äë[?25l[?25hass[?25l[?25hurance[?25l[?25h channel[?25l[?25h)[?25l[?25h and[?25l[?25h,[?25l[?25h if[?25l[?25h the[?25l[?25h response[?25l[?25h is[?25l[?25h inadequate[?25l[?25h,[?25l[?25h to[?25l[?25h the[?25l[?25h external[?25l[?25h regulator[?25l[?25h ([?25l[?25hthe[?25l[?25h FDA[?25l[?25h or[?25l[?25h the[?25l[?25h relevant[?25l[?25h health[?25l[?25h authority[?25l[?25h).[?25l[?25h [?25l[?25h Protect[?25l[?25hing[?25l[?25h patients[?25l[?25h,[?25l[?25h preserving[?25l[?25h scientific[?25l[?25h integrity[?25l[?25h,[?25l[?25h and[?25l[?25h honoring[?25l[?25h the[?25l[?25h social[?25l[?25h contract[?25l[?25h of[?25l[?25h the[?25l[?25h pharmaceutical[?25l[?25h industry[?25l[?25h outweigh[?25l[?25h any[?25l[?25h personal[?25l[?25h loyalty[?25l[?25h to[?25l[?25h the[?25l[?25h colleague[?25l[?25h or[?25l[?25h the short[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h financial[?25l[?25h interests[?25l[?25h of[?25l[?25h the[?25l[?25h firm[?25l[?25h.

[?25l[?25h---

[?25l[?25h##[?25l[?25h [?25l[?25h1[?25l[?25h.[?25l[?25h Identify[?25l[?25h the[?25l[?25h competing[?25l[?25h values[?25l[?25h and[?25l[?25h duties[?25l[?25h

[?25l[?25h|[?25l[?25h Stake[?25l[?25hholder[?25l[?25h |[?25l[?25h Primary[?25l[?25h Interests[?25l[?25h |[?25l[?25h Relevant[?25l[?25h Duties[?25l[?25h ([?25l[?25hProfessional/[?25l[?25hLegal[?25l[?25h/E[?25l[?25hth[?25l[?25hical[?25l[?25h)[?25l[?25h |
[?25l[?25h|[?25l[?25h-------------[?25l[?25h|[?25l[?25h----------------[?25l[?25h---[?25l[?25h|[?25l[?25h--------------------------------[?25l[?25h--------------[?25l[?25h|
[?25l[?25h|[?25l[?25h **[?25l[?25hPatients[?25l[?25h /[?25l[?25h Future[?25l[?25h trial[?25l[?25h participants[?25l[?25h**[?25l[?25h |[?25l[?25h Safety[?25l[?25h,[?25l[?25h right[?25l[?25h to[?25l[?25h truthful[?25l[?25h information[?25l[?25h about[?25l[?25h risks[?25l[?25h/[?25l[?25hbenef[?25l[?25hits[?25l[?25h |[?25l[?25h *[?25l[?25hBenef[?25l[?25hic[?25l[?25hence[?25l[?25h*[?25l[?25h ‚Äì[?25l[?25h act[?25l[?25h to[?25l[?25h do[?25l[?25h good[?25l[?25h;[?25l[?25h *[?25l[?25hNon[?25l[?25h‚Äë[?25l[?25hmal[?25l[?25hef[?25l[?25hic[?25l[?25hence[?25l[?25h*[?25l[?25h ‚Äì[?25l[?25h avoid[?25l[?25h causing harm;[?25l[?25h respect[?25l[?25h for[?25l[?25h autonomy[?25l[?25h ([?25l[?25hin[?25l[?25hformed[?25l[?25h consent[?25l[?25h).[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25hSoc[?25l[?25hiety[?25l[?25h /[?25l[?25h Public[?25l[?25h health[?25l[?25h**[?25l[?25h |[?25l[?25h Trust[?25l[?25h in[?25l[?25h medicines[?25l[?25h,[?25l[?25h fair[?25l[?25h allocation[?25l[?25h of[?25l[?25h resources[?25l[?25h |[?25l[?25h Protect[?25l[?25h public[?25l[?25h health[?25l[?25h;[?25l[?25h maintain[?25l[?25h integrity[?25l[?25h of[?25l[?25h the[?25l[?25h drug[?25l[?25h‚Äë[?25l[?25happroval[?25l[?25h process[?25l[?25h;[?25l[?25h uphold[?25l[?25h the[?25l[?25h social[?25l[?25h contract[?25l[?25h that[?25l[?25h pharmaceuticals[?25l[?25h are[?25l[?25h regulated[?25l[?25h for[?25l[?25h safety[?25l[?25h and[?25l[?25h efficacy[?25l[?25h.[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25hCompany[?25l[?25h ([?25l[?25hshareholders[?25l[?25h,[?25l[?25h employees[?25l[?25h)**[?25l[?25h |[?25l[?25h Profit[?25l[?25h,[?25l[?25h market[?25l[?25h reputation[?25l[?25h,[?25l[?25h regulatory[?25l[?25h compliance[?25l[?25h |[?25l[?25h Fid[?25l[?25huci[?25l[?25hary[?25l[?25h duty[?25l[?25h to[?25l[?25h shareholders[?25l[?25h to[?25l[?25h act[?25l[?25h law[?25l[?25hfully[?25l[?25h;[?25l[?25h legal[?25l[?25h duty[?25l[?25h to[?25l[?25h provide[?25l[?25h accurate[?25l[?25h data[?25l[?25h to[?25l[?25h regulators[?25l[?25h;[?25l[?25h responsibility[?25l[?25h to[?25l[?25h avoid[?25l[?25h costly[?25l[?25h recalls[?25l[?25h or[?25l[?25h litigation[?25l[?25h.[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25hCol[?25l[?25hleague[?25l[?25h who[?25l[?25h fals[?25l[?25hified[?25l[?25h data[?25l[?25h**[?25l[?25h |[?25l[?25h Job[?25l[?25h security[?25l[?25h,[?25l[?25h reputation[?25l[?25h |[?25l[?25h Professional[?25l[?25h duty[?25l[?25h to[?25l[?25h be[?25l[?25h honest[?25l[?25h;[?25l[?25h responsibility[?25l[?25h for[?25l[?25h remediation[?25l[?25h of[?25l[?25h one[?25l[?25h‚Äôs[?25l[?25h own[?25l[?25h misconduct[?25l[?25h.[?25l[?25h |
[?25l[?25h| **You[?25l[?25h ([?25l[?25hthe[?25l[?25h data[?25l[?25h scientist[?25l[?25h)**[?25l[?25h |[?25l[?25h Professional[?25l[?25h integrity[?25l[?25h,[?25l[?25h personal[?25l[?25h safety[?25l[?25h,[?25l[?25h career[?25l[?25h,[?25l[?25h moral[?25l[?25h conscience[?25l[?25h |[?25l[?25h Duty[?25l[?25h of[?25l[?25h *[?25l[?25hwh[?25l[?25histle[?25l[?25h‚Äë[?25l[?25hbl[?25l[?25howing[?25l[?25h*[?25l[?25h under[?25l[?25h many[?25l[?25h codes[?25l[?25h of[?25l[?25h conduct[?25l[?25h;[?25l[?25h duty[?25l[?25h to[?25l[?25h report[?25l[?25h unsafe[?25l[?25h practices[?25l[?25h;[?25l[?25h duty[?25l[?25h to[?25l[?25h protect[?25l[?25h yourself[?25l[?25h legally[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h keep[?25l[?25h documentation[?25l[?25h).[?25l[?25h |

[?25l[?25hThe[?25l[?25h conflict[?25l[?25h is[?25l[?25h between[?25l[?25h **[?25l[?25hshort[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h financial[?25l[?25h gain[?25l[?25h /[?25l[?25h colleague[?25l[?25h loyalty[?25l[?25h**[?25l[?25h and[?25l[?25h **[?25l[?25hlong[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h safety[?25l[?25h of[?25l[?25h patients[?25l[?25h and[?25l[?25h the[?25l[?25h ethical[?25l[?25h integrity[?25l[?25h of[?25l[?25h the[?25l[?25h scientific[?25l[?25h enterprise[?25l[?25h**[?25l[?25h.

[?25l[?25h---

[?25l[?25h##[?25l[?25h [?25l[?25h2[?25l[?25h.[?25l[?25h Apply[?25l[?25h the[?25l[?25h relevant[?25l[?25h ethical[?25l[?25h frameworks[?25l[?25h

[?25l[?25h###[?25l[?25h [?25l[?25h2[?25l[?25h.[?25l[?25h1[?25l[?25h.[?25l[?25h De[?25l[?25hont[?25l[?25hological[?25l[?25h ([?25l[?25hrule[?25l[?25h‚Äë[?25l[?25hbased[?25l[?25h)[?25l[?25h reasoning[?25l[?25h
[?25l[?25h-[?25l[?25h **[?25l[?25hProfessional[?25l[?25h codes[?25l[?25h**[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h *[?25l[?25hInternational[?25l[?25h Society[?25l[?25h for[?25l[?25h Pharmac[?25l[?25hoe[?25l[?25hconom[?25l[?25hics[?25l[?25h and[?25l[?25h Outcomes[?25l[?25h Research[?25l[?25h*,[?25l[?25h *[?25l[?25hAmerican[?25l[?25h Medical[?25l[?25h Association[?25l[?25h*,[?25l[?25h *[?25l[?25hPh[?25l[?25harmaceutical[?25l[?25h Research[?25l[?25h and[?25l[?25h Manufacturers[?25l[?25h of[?25l[?25h America[?25l[?25h*[?25l[?25h):[?25l[?25h ‚Äú[?25l[?25hDo[?25l[?25h not[?25l[?25h fabricate[?25l[?25h or[?25l[?25h fals[?25l[?25hify[?25l[?25h data[?25l[?25h.‚Äù[?25l[?25h  
[?25l[?25h-[?25l[?25h **[?25l[?25hLegal[?25l[?25h statutes[?25l[?25h**[?25l[?25h ([?25l[?25h21[?25l[?25h‚ÄØ[?25l[?25hU[?25l[?25h.S[?25l[?25h.C[?25l[?25h.[?25l[?25h ¬ß¬ß[?25l[?25h‚ÄØ[?25l[?25h355[?25l[?25h,[?25l[?25h [?25l[?25h331[?25l[?25h; EU[?25l[?25h Clinical[?25l[?25h Trials[?25l[?25h Regulation[?25l[?25h):[?25l[?25h F[?25l[?25hals[?25l[?25hification[?25l[?25h of[?25l[?25h clinical[?25l[?25h data[?25l[?25h is[?25l[?25h illegal[?25l[?25h;[?25l[?25h knowingly[?25l[?25h submitting[?25l[?25h false[?25l[?25h data[?25l[?25h is[?25l[?25h a[?25l[?25h *[?25l[?25hcriminal[?25l[?25h*[?25l[?25h act[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h **[?25l[?25hConclusion[?25l[?25h:**[?25l[?25h The[?25l[?25h *[?25l[?25hd[?25l[?25huty[?25l[?25h*[?25l[?25h to[?25l[?25h report[?25l[?25h fals[?25l[?25hification[?25l[?25h is[?25l[?25h absolute[?25l[?25h,[?25l[?25h irrespective of[?25l[?25h consequences[?25l[?25h.

[?25l[?25h###[?25l[?25h [?25l[?25h2[?25l[?25h.[?25l[?25h2[?25l[?25h.[?25l[?25h Util[?25l[?25hitarian[?25l[?25h ([?25l[?25hcon[?25l[?25hsequence[?25l[?25h‚Äë[?25l[?25hbased[?25l[?25h)[?25l[?25h reasoning[?25l[?25h
[?25l[?25h-[?25l[?25h **[?25l[?25hPotential[?25l[?25h harms[?25l[?25h if[?25l[?25h drug[?25l[?25h is[?25l[?25h approved[?25l[?25h on[?25l[?25h false[?25l[?25h data[?25l[?25h:**[?25l[?25h  
[?25l[?25h [?25l[?25h -[?25l[?25h Serious[?25l[?25h adverse[?25l[?25h events[?25l[?25h ‚Üí[?25l[?25h morbidity[?25l[?25h, mortality,[?25l[?25h costly[?25l[?25h lawsuits[?25l[?25h,[?25l[?25h loss[?25l[?25h of[?25l[?25h life[?25l[?25h.[?25l[?25h  
[?25l[?25h [?25l[?25h -[?25l[?25h Loss[?25l[?25h of[?25l[?25h public[?25l[?25h trust[?25l[?25h ‚Üí[?25l[?25h future[?25l[?25h drugs[?25l[?25h may[?25l[?25h be[?25l[?25h delayed[?25l[?25h,[?25l[?25h affecting[?25l[?25h millions[?25l[?25h.[?25l[?25h  
[?25l[?25h [?25l[?25h -[?25l[?25h Company[?25l[?25h fallout: product[?25l[?25h recall[?25l[?25h,[?25l[?25h massive[?25l[?25h financial[?25l[?25h penalties[?25l[?25h,[?25l[?25h possible[?25l[?25h bankruptcy[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h **[?25l[?25hPotential[?25l[?25h benefits[?25l[?25h of[?25l[?25h keeping[?25l[?25h quiet[?25l[?25h:**[?25l[?25h short[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h profit[?25l[?25h,[?25l[?25h colleague[?25l[?25h‚Äôs[?25l[?25h job[?25l[?25h,[?25l[?25h faster[?25l[?25h market[?25l[?25h entry[?25l[?25h.[?25l[?25h  
[?25l[?25h- **[?25l[?25hNet[?25l[?25h utility[?25l[?25h:**[?25l[?25h Reporting[?25l[?25h prevents[?25l[?25h far[?25l[?25h larger[?25l[?25h negative[?25l[?25h outcomes[?25l[?25h;[?25l[?25h any[?25l[?25h financial[?25l[?25h loss[?25l[?25h is[?25l[?25h outwe[?25l[?25highed[?25l[?25h by[?25l[?25h lives[?25l[?25h saved[?25l[?25h and[?25l[?25h long[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h reputation[?25l[?25h protection[?25l[?25h.

[?25l[?25h###[?25l[?25h [?25l[?25h2[?25l[?25h.[?25l[?25h3[?25l[?25h.[?25l[?25h Virt[?25l[?25hue[?25l[?25h ethics[?25l[?25h
[?25l[?25h-[?25l[?25h A[?25l[?25h virt[?25l[?25huous[?25l[?25h professional[?25l[?25h exhibits[?25l[?25h *[?25l[?25hintegr[?25l[?25hity[?25l[?25h,[?25l[?25h courage[?25l[?25h,[?25l[?25h honesty[?25l[?25h,*[?25l[?25h and[?25l[?25h *[?25l[?25hcomp[?25l[?25hassion[?25l[?25h*.[?25l[?25h  
[?25l[?25h-[?25l[?25h Conce[?25l[?25haling[?25l[?25h fraud[?25l[?25h would[?25l[?25h be[?25l[?25h a[?25l[?25h betrayal[?25l[?25h of[?25l[?25h those[?25l[?25h virtues[?25l[?25h;[?25l[?25h whistle‚Äë[?25l[?25hbl[?25l[?25howing[?25l[?25h reflects[?25l[?25h moral[?25l[?25h courage[?25l[?25h.

[?25l[?25h### 2[?25l[?25h.[?25l[?25h4[?25l[?25h.[?25l[?25h The[?25l[?25h ‚Äú[?25l[?25hFour[?25l[?25h Principles[?25l[?25h‚Äù[?25l[?25h of[?25l[?25h biomedical[?25l[?25h ethics[?25l[?25h ([?25l[?25hBe[?25l[?25hauch[?25l[?25hamp[?25l[?25h &[?25l[?25h Child[?25l[?25hress[?25l[?25h)
[?25l[?25h1[?25l[?25h.[?25l[?25h **[?25l[?25hBenef[?25l[?25hic[?25l[?25hence[?25l[?25h**[?25l[?25h ‚Äì[?25l[?25h act[?25l[?25h to[?25l[?25h benefit[?25l[?25h patients[?25l[?25h ‚Üí must stop a drug that could cause serious side‚Äëeffects.[?25l[?25h  
[?25l[?25h2[?25l[?25h.[?25l[?25h **[?25l[?25hNon[?25l[?25h‚Äë[?25l[?25hmal[?25l[?25hef[?25l[?25hic[?25l[?25hence[?25l[?25h**[?25l[?25h ‚Äì[?25l[?25h avoid[?25l[?25h harm[?25l[?25h ‚Üí[?25l[?25h fals[?25l[?25hified[?25l[?25h data[?25l[?25h masks[?25l[?25h harm[?25l[?25h.[?25l[?25h  
[?25l[?25h3.[?25l[?25h **[?25l[?25hJustice[?25l[?25h**[?25l[?25h ‚Äì[?25l[?25h fair[?25l[?25h distribution[?25l[?25h of[?25l[?25h risks[?25l[?25h/[?25l[?25hbenef[?25l[?25hits[?25l[?25h ‚Üí[?25l[?25h ignoring[?25l[?25h the[?25l[?25h data[?25l[?25h places[?25l[?25h an[?25l[?25h unfair[?25l[?25h burden[?25l[?25h on[?25l[?25h patients[?25l[?25h.[?25l[?25h  
[?25l[?25h4[?25l[?25h.[?25l[?25h **[?25l[?25hRespect[?25l[?25h for[?25l[?25h autonomy[?25l[?25h**[?25l[?25h ‚Äì[?25l[?25h patients[?25l[?25h can[?25l[?25h only[?25l[?25h make[?25l[?25h informed[?25l[?25h choices[?25l[?25h if[?25l[?25h the[?25l[?25h data[?25l[?25h are[?25l[?25h truthful[?25l[?25h.

[?25l[?25hAll[?25l[?25h four[?25l[?25h principles[?25l[?25h converge[?25l[?25h on[?25l[?25h the[?25l[?25h need[?25l[?25h to[?25l[?25h disclose[?25l[?25h the[?25l[?25h fals[?25l[?25hification[?25l[?25h.

[?25l[?25h---

[?25l[?25h##[?25l[?25h [?25l[?25h3[?25l[?25h.[?25l[?25h Step[?25l[?25h‚Äë[?25l[?25hby[?25l[?25h‚Äë[?25l[?25hstep[?25l[?25h decision[?25l[?25h pathway[?25l[?25h

### Step[?25l[?25h [?25l[?25h1[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hSecure[?25l[?25h the[?25l[?25h evidence[?25l[?25h**
[?25l[?25h-[?25l[?25h Copy[?25l[?25h the[?25l[?25h raw[?25l[?25h data[?25l[?25h files[?25l[?25h,[?25l[?25h statistical[?25l[?25h scripts[?25l[?25h,[?25l[?25h lab[?25l[?25h notebooks[?25l[?25h,[?25l[?25h and[?25l[?25h any[?25l[?25h email[?25l[?25h trails[?25l[?25h showing[?25l[?25h the[?25l[?25h manipulation[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Store[?25l[?25h them[?25l[?25h in[?25l[?25h a[?25l[?25h secure[?25l[?25h,[?25l[?25h access[?25l[?25h‚Äë[?25l[?25hcontrolled[?25l[?25h folder[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h encrypted[?25l[?25h company[?25l[?25h server[?25l[?25h or[?25l[?25h personal[?25l[?25h encrypted[?25l[?25h drive[?25l[?25h)[?25l[?25h and[?25l[?25h note[?25l[?25h timestamps[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Keep[?25l[?25h a[?25l[?25h written[?25l[?25h chronology of what[?25l[?25h you[?25l[?25h observed[?25l[?25h,[?25l[?25h when[?25l[?25h,[?25l[?25h and[?25l[?25h how[?25l[?25h you[?25l[?25h verified[?25l[?25h the[?25l[?25h discrepancy[?25l[?25h.

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h2[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hVerify[?25l[?25h that[?25l[?25h a[?25l[?25h mistake[?25l[?25h rather[?25l[?25h than[?25l[?25h intentional[?25l[?25h fraud[?25l[?25h**
[?25l[?25h-[?25l[?25h Request[?25l[?25h a[?25l[?25h **[?25l[?25hprivate[?25l[?25h,[?25l[?25h non[?25l[?25h‚Äë[?25l[?25hcon[?25l[?25hfront[?25l[?25hational[?25l[?25h**[?25l[?25h meeting[?25l[?25h with[?25l[?25h the[?25l[?25h colleague[?25l[?25h to[?25l[?25h discuss[?25l[?25h the[?25l[?25h discrepancy[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Give[?25l[?25h them[?25l[?25h an[?25l[?25h opportunity[?25l[?25h to[?25l[?25h explain[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h a[?25l[?25h cler[?25l[?25hical[?25l[?25h error[?25l[?25h,[?25l[?25h mis[?25l[?25h‚Äë[?25l[?25hlabel[?25l[?25hing[?25l[?25h).[?25l[?25h  
[?25l[?25h-[?25l[?25h If[?25l[?25h the[?25l[?25h explanation[?25l[?25h is[?25l[?25h impl[?25l[?25haus[?25l[?25hible[?25l[?25h or[?25l[?25h the[?25l[?25h correction[?25l[?25h does[?25l[?25h not[?25l[?25h resolve[?25l[?25h the[?25l[?25h discrepancy[?25l[?25h,[?25l[?25h you[?25l[?25h have[?25l[?25h confirmed[?25l[?25h intentional[?25l[?25h fals[?25l[?25hification[?25l[?25h.

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h3[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hEsc[?25l[?25hal[?25l[?25hate[?25l[?25h internally according[?25l[?25h to[?25l[?25h company[?25l[?25h policy[?25l[?25h**
[?25l[?25h1[?25l[?25h.[?25l[?25h **[?25l[?25hImmediate[?25l[?25h supervisor[?25l[?25h**[?25l[?25h ([?25l[?25hif[?25l[?25h it[?25l[?25h does[?25l[?25h not[?25l[?25h create[?25l[?25h a[?25l[?25h conflict[?25l[?25h of[?25l[?25h interest[?25l[?25h).[?25l[?25h  
[?25l[?25h2[?25l[?25h.[?25l[?25h **[?25l[?25hCompliance[?25l[?25h /[?25l[?25h Ethics[?25l[?25h hotline[?25l[?25h**[?25l[?25h ([?25l[?25hoften[?25l[?25h anonymous[?25l[?25h).[?25l[?25h  
[?25l[?25h3[?25l[?25h.[?25l[?25h **[?25l[?25hQuality[?25l[?25h‚Äë[?25l[?25hAss[?25l[?25hurance[?25l[?25h /[?25l[?25h Clinical[?25l[?25h‚Äë[?25l[?25hTrials[?25l[?25h Overs[?25l[?25hight[?25l[?25h team[?25l[?25h**[?25l[?25h.[?25l[?25h  

[?25l[?25hWhen[?25l[?25h reporting[?25l[?25h,[?25l[?25h provide[?25l[?25h:
[?25l[?25h-[?25l[?25h A[?25l[?25h concise[?25l[?25h factual[?25l[?25h statement[?25l[?25h ([?25l[?25hno[?25l[?25h speculation[?25l[?25h).[?25l[?25h  
[?25l[?25h-[?25l[?25h The[?25l[?25h documented[?25l[?25h evidence[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Your[?25l[?25h assessment[?25l[?25h of[?25l[?25h risk[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h ‚Äú[?25l[?25hBased[?25l[?25h on[?25l[?25h the[?25l[?25h un[?25l[?25halter[?25l[?25hed[?25l[?25h safety[?25l[?25h data[?25l[?25h,[?25l[?25h the[?25l[?25h incidence[?25l[?25h of[?25l[?25h X[?25l[?25h adverse[?25l[?25h event[?25l[?25h is Y[?25l[?25h%,[?25l[?25h which[?25l[?25h exceeds[?25l[?25h the[?25l[?25h FDA[?25l[?25h threshold[?25l[?25h for[?25l[?25h acceptable[?25l[?25h risk[?25l[?25h‚Äù).[?25l[?25h  

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h4[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hDocument[?25l[?25h the[?25l[?25h internal[?25l[?25h response[?25l[?25h**
[?25l[?25h-[?25l[?25h Record[?25l[?25h dates[?25l[?25h,[?25l[?25h names[?25l[?25h of[?25l[?25h recipients[?25l[?25h,[?25l[?25h and[?25l[?25h their[?25l[?25h reactions[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h If[?25l[?25h the[?25l[?25h company[?25l[?25h promises to[?25l[?25h investigate[?25l[?25h,[?25l[?25h obtain[?25l[?25h a[?25l[?25h written[?25l[?25h acknowledgment[?25l[?25h of[?25l[?25h the[?25l[?25h issue[?25l[?25h and[?25l[?25h a[?25l[?25h timeline[?25l[?25h for[?25l[?25h action[?25l[?25h.

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h5[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hAssess[?25l[?25h the[?25l[?25h adequ[?25l[?25hacy[?25l[?25h of[?25l[?25h the[?25l[?25h internal[?25l[?25h response[?25l[?25h**
[?25l[?25h-[?25l[?25h If[?25l[?25h the[?25l[?25h company[?25l[?25h **[?25l[?25him[?25l[?25hmediately[?25l[?25h**[?25l[?25h hal[?25l[?25hts[?25l[?25h the[?25l[?25h submission[?25l[?25h,[?25l[?25h initi[?25l[?25hates[?25l[?25h a[?25l[?25h full[?25l[?25h audit[?25l[?25h,[?25l[?25h and[?25l[?25h not[?25l[?25hifies[?25l[?25h the[?25l[?25h regulator[?25l[?25h ‚Üí[?25l[?25h you[?25l[?25h have[?25l[?25h fulfilled[?25l[?25h your[?25l[?25h duty[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h If[?25l[?25h the[?25l[?25h response[?25l[?25h is[?25l[?25h **[?25l[?25hdel[?25l[?25hayed[?25l[?25h,[?25l[?25h inadequate[?25l[?25h, or attempts[?25l[?25h to[?25l[?25h conceal[?25l[?25h**[?25l[?25h the[?25l[?25h problem[?25l[?25h,[?25l[?25h you[?25l[?25h must[?25l[?25h consider[?25l[?25h external[?25l[?25h reporting[?25l[?25h.

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h6[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hExternal[?25l[?25h reporting[?25l[?25h ([?25l[?25hwh[?25l[?25histle[?25l[?25h‚Äë[?25l[?25hbl[?25l[?25howing[?25l[?25h)[?25l[?25h**
[?25l[?25h-[?25l[?25h Contact[?25l[?25h the[?25l[?25h **[?25l[?25hFDA[?25l[?25h‚Äôs[?25l[?25h Office[?25l[?25h of[?25l[?25h Criminal[?25l[?25h Investig[?25l[?25hations** ([?25l[?25hor[?25l[?25h the[?25l[?25h relevant[?25l[?25h national[?25l[?25h regulator[?25l[?25h).  
-[?25l[?25h Provide[?25l[?25h the[?25l[?25h same[?25l[?25h evidence[?25l[?25h you[?25l[?25h gave[?25l[?25h internally[?25l[?25h,[?25l[?25h along[?25l[?25h with[?25l[?25h a[?25l[?25h concise[?25l[?25h timeline[?25l[?25h of[?25l[?25h internal[?25l[?25h communications[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Request[?25l[?25h confidentiality[?25l[?25h;[?25l[?25h most[?25l[?25h jurisdictions[?25l[?25h protect[?25l[?25h whistle[?25l[?25h‚Äë[?25l[?25hbl[?25l[?25howers[?25l[?25h from[?25l[?25h retaliation[?25l[?25h.

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h7[?25l[?25h ‚Äì[?25l[?25h **Protect[?25l[?25h yourself[?25l[?25h**
[?25l[?25h-[?25l[?25h Ret[?25l[?25hain[?25l[?25h copies[?25l[?25h of[?25l[?25h all[?25l[?25h correspondence[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h If[?25l[?25h you[?25l[?25h belong[?25l[?25h to[?25l[?25h a[?25l[?25h professional[?25l[?25h society[?25l[?25h,[?25l[?25h inform[?25l[?25h their[?25l[?25h ethics[?25l[?25h board[?25l[?25h ([?25l[?25hthey[?25l[?25h can[?25l[?25h offer[?25l[?25h legal[?25l[?25h support[?25l[?25h).[?25l[?25h  
[?25l[?25h-[?25l[?25h Consider[?25l[?25h obtaining[?25l[?25h legal[?25l[?25h counsel[?25l[?25h familiar[?25l[?25h with[?25l[?25h whistle[?25l[?25h‚Äë[?25l[?25hblower[?25l[?25h law[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h the[?25l[?25h U[?25l[?25h.S[?25l[?25h.[?25l[?25h‚ÄØ[?25l[?25hWh[?25l[?25histle[?25l[?25hblower[?25l[?25h Protection[?25l[?25h Act[?25l[?25h,[?25l[?25h the[?25l[?25h False[?25l[?25h Claims[?25l[?25h Act[?25l[?25h,[?25l[?25h or[?25l[?25h EU[?25l[?25h Wh[?25l[?25histle[?25l[?25hblower[?25l[?25h Directive[?25l[?25h).

[?25l[?25h###[?25l[?25h Step[?25l[?25h [?25l[?25h8[?25l[?25h ‚Äì[?25l[?25h **[?25l[?25hFollow[?25l[?25h up[?25l[?25h and[?25l[?25h mitigate collateral[?25l[?25h harm[?25l[?25h**
[?25l[?25h-[?25l[?25h Offer[?25l[?25h to[?25l[?25h assist[?25l[?25h the[?25l[?25h investigative[?25l[?25h team[?25l[?25h ([?25l[?25hinternal[?25l[?25h or[?25l[?25h external[?25l[?25h)[?25l[?25h in[?25l[?25h re[?25l[?25h‚Äë[?25l[?25han[?25l[?25haly[?25l[?25hzing[?25l[?25h the[?25l[?25h data[?25l[?25h correctly[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Suggest[?25l[?25h a[?25l[?25h *[?25l[?25hcontrolled[?25l[?25h*[?25l[?25h re[?25l[?25h‚Äë[?25l[?25hrun[?25l[?25h of[?25l[?25h the[?25l[?25h trial or[?25l[?25h a[?25l[?25h supplemental[?25l[?25h safety[?25l[?25h study[?25l[?25h to[?25l[?25h obtain[?25l[?25h reliable[?25l[?25h data[?25l[?25h.[?25l[?25h  
[?25l[?25h-[?25l[?25h Commun[?25l[?25hicate[?25l[?25h,[?25l[?25h where[?25l[?25h appropriate[?25l[?25h,[?25l[?25h with[?25l[?25h the[?25l[?25h **[?25l[?25hclinical[?25l[?25h‚Äë[?25l[?25htrial[?25l[?25h participants[?25l[?25h**[?25l[?25h ([?25l[?25hthrough[?25l[?25h the[?25l[?25h Institutional[?25l[?25h Review[?25l[?25h Board[?25l[?25h)[?25l[?25h to[?25l[?25h ensure[?25l[?25h they[?25l[?25h are[?25l[?25h informed[?25l[?25h of[?25l[?25h any[?25l[?25h new[?25l[?25h risk[?25l[?25h.

[?25l[?25h---

[?25l[?25h##[?25l[?25h [?25l[?25h4[?25l[?25h.[?25l[?25h Ant[?25l[?25hicip[?25l[?25hating[?25l[?25h and[?25l[?25h addressing[?25l[?25h objections[?25l[?25h

[?25l[?25h|[?25l[?25h Ob[?25l[?25hjection[?25l[?25h |[?25l[?25h Why[?25l[?25h it[?25l[?25h fails[?25l[?25h under[?25l[?25h ethical[?25l[?25h analysis[?25l[?25h |
[?25l[?25h|[?25l[?25h-----------[?25l[?25h|[?25l[?25h--------------------------------[?25l[?25h------[?25l[?25h|
[?25l[?25h|[?25l[?25h **[?25l[?25h‚Äú[?25l[?25hThe[?25l[?25h drug[?25l[?25h will[?25l[?25h save[?25l[?25h many[?25l[?25h lives[?25l[?25h;[?25l[?25h a[?25l[?25h small[?25l[?25h risk[?25l[?25h is[?25l[?25h acceptable[?25l[?25h.‚Äù[?25l[?25h**[?25l[?25h |[?25l[?25h The[?25l[?25h *[?25l[?25hrisk[?25l[?25h*[?25l[?25h is[?25l[?25h **[?25l[?25hunknown[?25l[?25h**[?25l[?25h because[?25l[?25h the[?25l[?25h safety[?25l[?25h data[?25l[?25h are[?25l[?25h fabricated[?25l[?25h.[?25l[?25h Acting[?25l[?25h without[?25l[?25h accurate[?25l[?25h risk[?25l[?25h quant[?25l[?25hification[?25l[?25h violates[?25l[?25h *[?25l[?25hnon[?25l[?25h‚Äë[?25l[?25hmal[?25l[?25hef[?25l[?25hicence*[?25l[?25h and[?25l[?25h the[?25l[?25h principle[?25l[?25h of[?25l[?25h informed[?25l[?25h consent[?25l[?25h.[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25h‚Äú[?25l[?25hThe[?25l[?25h company[?25l[?25h will[?25l[?25h suffer[?25l[?25h financially[?25l[?25h;[?25l[?25h jobs[?25l[?25h will[?25l[?25h be[?25l[?25h lost[?25l[?25h.‚Äù[?25l[?25h**[?25l[?25h |[?25l[?25h The[?25l[?25h *[?25l[?25hreal[?25l[?25h*[?25l[?25h risk[?25l[?25h is[?25l[?25h loss of **[?25l[?25hall[?25l[?25h**[?25l[?25h jobs[?25l[?25h if[?25l[?25h the[?25l[?25h drug[?25l[?25h is[?25l[?25h later[?25l[?25h withdrawn[?25l[?25h after[?25l[?25h causing[?25l[?25h harm[?25l[?25h ([?25l[?25hmass[?25l[?25h litigation[?25l[?25h,[?25l[?25h loss[?25l[?25h of[?25l[?25h reputation[?25l[?25h).[?25l[?25h Protect[?25l[?25hing[?25l[?25h a[?25l[?25h few[?25l[?25h jobs[?25l[?25h today does[?25l[?25h not[?25l[?25h outweigh[?25l[?25h the[?25l[?25h catastrophic[?25l[?25h downstream[?25l[?25h consequences[?25l[?25h.[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25h‚Äú[?25l[?25hI[?25l[?25h should[?25l[?25h protect[?25l[?25h my[?25l[?25h colleague[?25l[?25h;[?25l[?25h they[?25l[?25h made[?25l[?25h a[?25l[?25h mistake[?25l[?25h.‚Äù[?25l[?25h**[?25l[?25h |[?25l[?25h Professional[?25l[?25h integrity[?25l[?25h oblig[?25l[?25hes[?25l[?25h you[?25l[?25h to[?25l[?25h *[?25l[?25hcorrect[?25l[?25h*[?25l[?25h the[?25l[?25h mistake[?25l[?25h,[?25l[?25h not[?25l[?25h conceal it.[?25l[?25h Allow[?25l[?25hing[?25l[?25h the[?25l[?25h error[?25l[?25h to[?25l[?25h persist[?25l[?25h end[?25l[?25hangers[?25l[?25h patients[?25l[?25h and[?25l[?25h compromises[?25l[?25h scientific[?25l[?25h credibility[?25l[?25h.[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25h‚Äú[?25l[?25hI[?25l[?25h can[?25l[?25h fix[?25l[?25h the[?25l[?25h data[?25l[?25h quietly[?25l[?25h and[?25l[?25h submit[?25l[?25h a[?25l[?25h corrected[?25l[?25h report[?25l[?25h.‚Äù[?25l[?25h**[?25l[?25h |[?25l[?25h *[?25l[?25hTam[?25l[?25hpering[?25l[?25h*[?25l[?25h further[?25l[?25h would[?25l[?25h constitute[?25l[?25h *[?25l[?25hob[?25l[?25hstruction[?25l[?25h of[?25l[?25h justice[?25l[?25h*[?25l[?25h and[?25l[?25h could[?25l[?25h be[?25l[?25h criminal.[?25l[?25h The[?25l[?25h correct[?25l[?25h path[?25l[?25h is[?25l[?25h a[?25l[?25h transparent[?25l[?25h investigation[?25l[?25h,[?25l[?25h not[?25l[?25h a[?25l[?25h covert[?25l[?25h correction[?25l[?25h.[?25l[?25h |
[?25l[?25h|[?25l[?25h **[?25l[?25h‚Äú[?25l[?25hReporting[?25l[?25h will[?25l[?25h ruin[?25l[?25h my[?25l[?25h career[?25l[?25h.‚Äù[?25l[?25h**[?25l[?25h |[?25l[?25h Wh[?25l[?25histle[?25l[?25h‚Äë[?25l[?25hblower[?25l[?25h statutes[?25l[?25h ([?25l[?25he[?25l[?25h.g[?25l[?25h.,[?25l[?25h [?25l[?25h18[?25l[?25h‚ÄØ[?25l[?25hU[?25l[?25h.S[?25l[?25h.C[?25l[?25h.[?25l[?25h‚ÄØ[?25l[?25h¬ß[?25l[?25h‚ÄØ[?25l[?25h2339)[?25l[?25h provide[?25l[?25h legal[?25l[?25h protection[?25l[?25h.[?25l[?25h Moreover[?25l[?25h,[?25l[?25h a[?25l[?25h reputation[?25l[?25h built[?25l[?25h on[?25l[?25h integrity[?25l[?25h is[?25l[?25h more[?25l[?25h sustainable[?25l[?25h than[?25l[?25h one[?25l[?25h built[?25l[?25h on[?25l[?25h cover[?25l[?25h‚Äë[?25l[?25hups[?25l[?25h. |

[?25l[?25h---

[?25l[?25h##[?25l[?25h [?25l[?25h5[?25l[?25h.[?25l[?25h The[?25l[?25h final[?25l[?25h ethical[?25l[?25h position[?25l[?25h ([?25l[?25hconc[?25l[?25hise[?25l[?25h)

[?25l[?25h1[?25l[?25h.[?25l[?25h **[?25l[?25hPatient[?25l[?25h safety[?25l[?25h and[?25l[?25h truthful[?25l[?25h scientific[?25l[?25h communication[?25l[?25h are[?25l[?25h non[?25l[?25h‚Äë[?25l[?25hneg[?25l[?25hoti[?25l[?25hable[?25l[?25h ethical[?25l[?25h imper[?25l[?25hatives[?25l[?25h.[?25l[?25h**[?25l[?25h  
[?25l[?25h2[?25l[?25h.[?25l[?25h **[?25l[?25hF[?25l[?25hals[?25l[?25hification[?25l[?25h of[?25l[?25h clinical[?25l[?25h data[?25l[?25h is[?25l[?25h both[?25l[?25h a[?25l[?25h breach[?25l[?25h of[?25l[?25h professional[?25l[?25h ethics[?25l[?25h and[?25l[?25h a[?25l[?25h legal[?25l[?25h violation[?25l[?25h.[?25l[?25h**[?25l[?25h  
[?25l[?25h3[?25l[?25h.[?25l[?25h **[?25l[?25hYour[?25l[?25h primary[?25l[?25h duty[?25l[?25h is[?25l[?25h to[?25l[?25h report[?25l[?25h the[?25l[?25h misconduct[?25l[?25h**[?25l[?25h ‚Äì[?25l[?25h first[?25l[?25h through[?25l[?25h the[?25l[?25h company[?25l[?25h‚Äôs[?25l[?25h formal[?25l[?25h channels[?25l[?25h,[?25l[?25h then[?25l[?25h,[?25l[?25h if[?25l[?25h necessary[?25l[?25h,[?25l[?25h to[?25l[?25h the[?25l[?25h external[?25l[?25h regulator[?25l[?25h.[?25l[?25h  
[?25l[?25h4[?25l[?25h.[?25l[?25h **[?25l[?25hYou[?25l[?25h must[?25l[?25h protect[?25l[?25h the[?25l[?25h evidence[?25l[?25h and[?25l[?25h yourself[?25l[?25h**[?25l[?25h ([?25l[?25hdocument[?25l[?25h everything[?25l[?25h,[?25l[?25h seek[?25l[?25h confidential[?25l[?25h counsel[?25l[?25h).[?25l[?25h  
[?25l[?25h5[?25l[?25h.[?25l[?25h **[?25l[?25hWhile[?25l[?25h the[?25l[?25h outcome[?25l[?25h may[?25l[?25h cause[?25l[?25h short[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h financial[?25l[?25h loss[?25l[?25h and[?25l[?25h a[?25l[?25h colleague[?25l[?25h‚Äôs[?25l[?25h dismissal[?25l[?25h,[?25l[?25h the[?25l[?25h alternative[?25l[?25h‚Äî[?25l[?25hallow[?25l[?25hing[?25l[?25h a[?25l[?25h potentially[?25l[?25h unsafe[?25l[?25h drug[?25l[?25h onto[?25l[?25h the[?25l[?25h market[?25l[?25h‚Äî[?25l[?25hposes far[?25l[?25h greater[?25l[?25h harm[?25l[?25h to[?25l[?25h patients[?25l[?25h,[?25l[?25h the[?25l[?25h public[?25l[?25h,[?25l[?25h and[?25l[?25h the[?25l[?25h long[?25l[?25h‚Äë[?25l[?25hterm[?25l[?25h viability[?25l[?25h of[?25l[?25h the[?25l[?25h company[?25l[?25h.[?25l[?25h**

[?25l[?25h---

[?25l[?25h###[?25l[?25h Quick[?25l[?25h Checklist[?25l[?25h ([?25l[?25hfor[?25l[?25h immediate[?25l[?25h use[?25l[?25h)

[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h Secure[?25l[?25h all[?25l[?25h raw[?25l[?25h data[?25l[?25h &[?25l[?25h documentation[?25l[?25h ([?25l[?25htimestamps[?25l[?25h)[?25l[?25h |
[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h Confirm[?25l[?25h it[?25l[?25h is[?25l[?25h not[?25l[?25h a[?25l[?25h simple[?25l[?25h cler[?25l[?25hical[?25l[?25h error[?25l[?25h ([?25l[?25hprivate[?25l[?25h discussion[?25l[?25h)[?25l[?25h |
[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h Report[?25l[?25h to[?25l[?25h immediate[?25l[?25h supervisor[?25l[?25h /[?25l[?25h compliance[?25l[?25h hotline[?25l[?25h ([?25l[?25hwritten[?25l[?25h)[?25l[?25h |
[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h Keep[?25l[?25h a[?25l[?25h log[?25l[?25h of[?25l[?25h internal responses[?25l[?25h ([?25l[?25hdates[?25l[?25h,[?25l[?25h names[?25l[?25h,[?25l[?25h actions[?25l[?25h)[?25l[?25h |
[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h If[?25l[?25h uns[?25l[?25hatisfied[?25l[?25h,[?25l[?25h contact[?25l[?25h the[?25l[?25h FDA[?25l[?25h ([?25l[?25hor[?25l[?25h national[?25l[?25h regulator[?25l[?25h)[?25l[?25h |
[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h Preserve[?25l[?25h copies[?25l[?25h,[?25l[?25h seek[?25l[?25h legal[?25l[?25h counsel[?25l[?25h,[?25l[?25h invoke[?25l[?25h whistle[?25l[?25h‚Äë[?25l[?25hblower[?25l[?25h protection[?25l[?25h |
[?25l[?25h|[?25l[?25h ‚òê[?25l[?25h [?25l[?25h Offer[?25l[?25h to[?25l[?25h help[?25l[?25h redesign[?25l[?25h or[?25l[?25h re[?25l[?25h‚Äë[?25l[?25hrun the[?25l[?25h trial[?25l[?25h to[?25l[?25h obtain[?25l[?25h valid[?25l[?25h safety[?25l[?25h data[?25l[?25h |

[?25l[?25hBy[?25l[?25h following[?25l[?25h this[?25l[?25h structured[?25l[?25h,[?25l[?25h principled approach[?25l[?25h you[?25l[?25h honor[?25l[?25h your[?25l[?25h professional[?25l[?25h responsibilities[?25l[?25h,[?25l[?25h safeguard[?25l[?25h patients[?25l[?25h,[?25l[?25h and[?25l[?25h uphold[?25l[?25h the[?25l[?25h integrity[?25l[?25h of[?25l[?25h the[?25l[?25h entire[?25l[?25h drug[?25l[?25h‚Äë[?25l[?25hdevelopment[?25l[?25h ecosystem[?25l[?25h‚Äî[?25l[?25hexact[?25l[?25hly the duties[?25l[?25h a[?25l[?25h data[?25l[?25h scientist[?25l[?25h in[?25l[?25h pharma[?25l[?25h is[?25l[?25h entrusted[?25l[?25h with[?25l[?25h.[?25l[?25h[?25l[?25h

[?25l[?25h